Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA grants orphan drug status to Pulmatrix's PUR1900

Thursday, August 18, 2016

Pulmatrix receives orphan drug designation from the FDA for inhaled drug to treat pulmonary fungal infections in cystic fibrosis patients FDA granted cos request for orphan drug status for drug for treating pulmonary fungal infections in cystic fibr...

Sasmar Pharmaceuticals Announces Acquisition of Aquatrove BioSciences, Inc.

Thursday, August 18, 2016

Sasmar Pharmaceuticals announced that is has acquired Aquatrove Biosciences Inc a biotechnology company focused on discovery research and development in human reproductive health and fertility Under the terms of the agreement Sasmar through its Aust...

Strides Shasun completes acquisition of Generic Partners

Wednesday, August 17, 2016

Drug firm Strides Shasun today said it has completed acquisition of a controlling stake in Australiabased Generic Partners Holdings We refer to our press release dated February on acquisition of strategic stake in Generic Partners Holdings Austral...

OncoGenex seeks strategic alternatives after drug study fails

Wednesday, August 17, 2016

OncoGenex Pharmaceuticals Inc said it was exploring strategic alternatives after its experimental drug failed to show survival benefit in a latestage study in patients with advanced prostate cancer The Bothell Washingtonbased companys stock tumbled...

Asia’s Pharma Investment Shows the Benefit of Patent Protection

Wednesday, August 17, 2016

Next month in New York the United Nations will launch its longawaited High Level Report on access to medicines The UN hopes this will resolve the debate around intellectual property rights and access to medicines Leaked versions of the report sugges...

Piramal Pharma Solutions announces the intent to acquire Ash Stevens

Wednesday, August 17, 2016

Ash Stevens Inc a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient API manufacturing services is pleased to announce that the company has been acquired by Piramal Pharma Solutions a wo...

Hedge funds made big changes at drug companies in second quarter

Tuesday, August 16, 2016

For many prominent hedge fund managers who bet Pfizer Inc and Allergan Plc would merge to become the worlds biggest pharmaceuticals company the second quarter started with a thud that sent many in search of new opportunities John Griffins Blue Ridge...

Astrazeneca Closes Global Licencing Deal With Leo Pharma For Tralokinumab

Tuesday, August 16, 2016

AstraZeneca said that it has completed the licensing agreement with LEO Pharma AS a specialist in dermatology care for the global licence to tralokinumab in skin diseases Tralokinumab is an IL monoclonal antibody that has completed a Phase IIb trial...

AcelRx Pharmaceuticals says ARX-04 phase 3 trial met primary endpoint

Tuesday, August 16, 2016

AcelRx Pharmaceuticals Inc Overall ARX was well tolerated in study with of patients reporting no adverse events Topline results from singlearm openlabel phase sap trial which assessed ARX in patients with pain related to trauma or injury AcelRx Ph...

Scintilla Pharmaceuticals, a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals

Tuesday, August 16, 2016

Scintilla Pharmaceuticals Inc a subsidiary of Sorrento Therapeutics Inc has entered into a binding term sheet to acquire Semnur Pharmaceuticals Inc Semnur Scintillas lead program is resiniferatoxin RTX for the treatment of intractable cancer pain Se...